Christophe Lehain looks back over the last three years and the ambitions of Asept InMed

Asept InMed, a subsidiary of the Medi-Globe group recently acquired by investor Duke Street, has grown significantly over the past three years. With 28% growth between 2016 and 2018, this French company specialising in the distribution of medical devices is now one of the top 5% of French companies rated by the Banque de France.

In recent years, 23 new positions have been created, mainly in sales (due to the creation of a third sales force) and marketing. Asept InMed has also integrated new exclusive industrial partners in consideration of changing market requirements and the need to provide better transparency to customers.

Finally, the company does not hesitate to surf the wave of digitalization with the development of its web presence both internally and externally. This constant evolution is based on 3 essential pillars: expertise, entrepreneurial spirit and team spirit in line with Asept InMed's values.